tetano
Editor, Senior Moderator
Cardiol Clin
. 2022 Aug;40(3):321-328.
doi: 10.1016/j.ccl.2022.03.007. Epub 2022 Mar 29.
A Review of ST-Elevation Myocardial Infarction in Patients with COVID-19
Nima Ghasemzadeh[SUP] 1 [/SUP], Nathan Kim[SUP] 2 [/SUP], Shy Amlani[SUP] 3 [/SUP], Mina Madan[SUP] 4 [/SUP], Jay S Shavadia[SUP] 5 [/SUP], Aun-Yeong Chong[SUP] 6 [/SUP], Alireza Bagherli[SUP] 7 [/SUP], Akshay Bagai[SUP] 8 [/SUP], Jacqueline Saw[SUP] 9 [/SUP], Jyotpal Singh[SUP] 10 [/SUP], Payam Dehghani[SUP] 11 [/SUP]
Affiliations
Abstract
The Coronavirus disease 2019 (COVID-19) pandemic has led to a significant increase in worldwide morbidity and mortality. Patients with COVID-19 are at risk for developing a variety of cardiovascular conditions including acute coronary syndromes, stress-induced cardiomyopathy, and myocarditis. Patients with COVID-19 who develop ST-elevation myocardial infarction (STEMI) are at a higher risk of morbidity and mortality when compared with their age- and sex-matched STEMI patients without COVID-19. We review current knowledge on the pathophysiology of STEMI in patients with COVID-19, clinical presentation, outcomes, and the effect of the COVID-19 pandemic on overall STEMI care.
Keywords: COVID-19; SARS-COV 2; ST-Elevation myocardial infarction.
. 2022 Aug;40(3):321-328.
doi: 10.1016/j.ccl.2022.03.007. Epub 2022 Mar 29.
A Review of ST-Elevation Myocardial Infarction in Patients with COVID-19
Nima Ghasemzadeh[SUP] 1 [/SUP], Nathan Kim[SUP] 2 [/SUP], Shy Amlani[SUP] 3 [/SUP], Mina Madan[SUP] 4 [/SUP], Jay S Shavadia[SUP] 5 [/SUP], Aun-Yeong Chong[SUP] 6 [/SUP], Alireza Bagherli[SUP] 7 [/SUP], Akshay Bagai[SUP] 8 [/SUP], Jacqueline Saw[SUP] 9 [/SUP], Jyotpal Singh[SUP] 10 [/SUP], Payam Dehghani[SUP] 11 [/SUP]
Affiliations
- PMID: 35851455
- DOI: 10.1016/j.ccl.2022.03.007
Abstract
The Coronavirus disease 2019 (COVID-19) pandemic has led to a significant increase in worldwide morbidity and mortality. Patients with COVID-19 are at risk for developing a variety of cardiovascular conditions including acute coronary syndromes, stress-induced cardiomyopathy, and myocarditis. Patients with COVID-19 who develop ST-elevation myocardial infarction (STEMI) are at a higher risk of morbidity and mortality when compared with their age- and sex-matched STEMI patients without COVID-19. We review current knowledge on the pathophysiology of STEMI in patients with COVID-19, clinical presentation, outcomes, and the effect of the COVID-19 pandemic on overall STEMI care.
Keywords: COVID-19; SARS-COV 2; ST-Elevation myocardial infarction.